Article info
PDFOriginal research
Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium
- Correspondence to Dr Dimitrios Nasioudis, Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA; dimitrios.nasioudis{at}uphs.upenn.edu
Citation
Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium
Publication history
- Received March 10, 2020
- Revision received June 5, 2020
- Accepted June 9, 2020
- First published July 15, 2020.
Article Versions
- You are currently viewing a Previous version of this article (8 February 2021).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.